Atlas FDA

DEXTRAN HM 32% HYSTEROSCOPIC DISTENTION MEDIUM

FDA premarket approval P880028/S007 · decided 1996-09-05

Approval details

PMA number
P880028
Supplement
S007
Supplement type
Normal 180 Day Track
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
DEXTRAN HM 32% HYSTEROSCOPIC DISTENTION MEDIUM
Generic name
FLUID, HYSTEROSCOPY
Applicant
Hospira, Inc.
Date received
1996-04-02
Decision date
1996-09-05
Days to decision
156 days
Decision code
APPR
Product code
LTA
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Lake Forest, IL
Statement
APPROVAL TO ALLOW FOR THE ROUTINE PARAMETRIC RELEASE OF TERMINALLY MOIST-HEAT STERILIZED SOLUTIONS BY THE OCNTROL OF PROCESS PARAMETERS FOR DEXTROSE HM 32%

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Plum 360(TM) Infusion System with MedNet/ Smart Card Plug and Play Module (K161469)Hospira, Inc.2017-03-28
Hospira Extension Set, Hospira Primary Set (K161036)Hospira, Inc.2017-01-06
Hospira Sapphire Sets (K160492)Hospira, Inc.2016-12-06
Hospira Administration Sets (K160870)Hospira, Inc.2016-06-01
LifeCare PCA Infusion System (K143612)Hospira, Inc.2016-04-08
Hospira Blood Set (K143087)Hospira, Inc.2015-03-04
Hospira Primary Sets (K143015)Hospira, Inc.2015-02-25
PLUM 360 INFUSION SYSTEM WITH HOSPIRA MEDNET, SMART CARD PLUG N PLAY CE 3.0 MODULE FOR PLUM A+ INFUSION SYSTEM UPGRADE (K141789)Hospira, Inc.2015-01-16